During the past decade, Hôpital Jean-Bernard conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hôpital Jean-Bernard" #1 sponsor was "Groupe Francophone des Myelodysplasies" with 8 trials, followed by "European Organisation for Research and Treatment of Cancer - EORTC" with 7 trials sponsored, "UNICANCER" with 5 trials sponsored, "Poitiers University Hospital" with 2 trials sponsored and "University Hospital, Tours" with 2 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hôpital Jean-Bernard" #1 collaborator was "Roche Pharma AG" with 5 trials as a collaborator, "Celgene Corporation" with 3 trials as a collaborator, "Celgene" with 2 trials as a collaborator, "SFCE" with 2 trials as a collaborator and "Astellas Pharma Inc" with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Hôpital Jean-Bernard" are "Myelodysplastic Syndromes" (9 trials), "Leukemia" (4 trials), "Breast Cancer" (2 trials), "Lymphoma" (2 trials) and "Multiple Myeloma" (2 trials). Many other conditions were trialed in "Hôpital Jean-Bernard" in a lesser frequency.

Most popular intervention types in "Hôpital Jean-Bernard" are "Drug" (29 trials), "Procedure" (10 trials), "Radiation" (7 trials), "Biological" (3 trials) and "Genetic" (2 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (6 trials), "cisplatin" (5 trials), "etoposide" (4 trials), "fluorouracil" (4 trials) and "Azacitidine" (3 trials). Other intervention names were less common.

The vast majority of trials in "Hôpital Jean-Bernard" are 30 trials for "All" genders, 2 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Hôpital Jean-Bernard". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 22 completed trials in Hôpital Jean-Bernard, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Hôpital Jean-Bernard, 3 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".

Hôpital Jean-Bernard has several departments that took part in Clinical trials: "CHU Poitiers - Pôle régional de Cancérologie" - 19 trials, "Intensive reanimation" - 4 trials